Synbio Outlines Two-Engine Healthcare Growth Strategy
Synbio is advancing a two-engine healthcare growth strategy combining nutraceuticals and AI-powered mental health screening. The company is initiating a commercial launch through an exclusive U.S. and Canada licensing deal and its FacialDx NIMS™ clinical program is progressing towards an Australian feasibility study.